Welcome to Marc Fadel, Head of Clinic specialised in occupational health!
In May 2022, Marc Fadel, head of clinic at the CHU of Angers, joined the ReWork team of the SIRIC
Physical activity, a lever for returning to work after cancer
Is physical activity a lever for a return to work after cancer? This question was the subject of a study
“This protected medical time supported by the SIRIC allows me to make the link between the clinic and the research laboratories, so that the results obtained are linked to the medical reality of the patients. – Jean-Sébastien Frenel
Doctor Jean-Sébastien Frenel, an oncologist at the Institut de Cancérologie de l’Ouest, has benefited from “protected medical time” since 1
SIRIC ILIAD is proud to share the “Cancer & Work Guide – Breast Cancer
On the occasion of World Cancer Day, the SIRIC ILIAD Nantes-Angers (Integrated Cancer Research Site supported by the Nantes University
Welcome to Eric Letouzé, Connect Talent Pays de la Loire laureate and director of cancer genomics research
What is a Connect Talent? « The Connect Talent initiative of the Pays de la Loire region aims to support
SAVE THE DATE | Meeting on minds on Breast Cancer: From Research to Patients – 6 Oct 2021
The SIRIC ILIAD and the Cancéropôle Grand Ouest (CGO) are organising a public event on breast cancer as part
Returning to work after cancer: the ReWork programme presented in a video
Video : ReWork a research programme to facilitate return to work The SIRIC ILIAD Nantes-Angers (Integrated Cancer Research Site) was
The facade of GIP Arronax is transformed into an open-air exhibition on theranostics
Since 4 June, the eastern façade of GIP ARRONAX has been transformed into an open-air exhibition: “Theranostics, towards personalised nuclear
Pink October 2020: SIRIC ILIAD alongside the Amazones association!
Pink October 2020: SIRIC ILIAD was present in Martinique alongside the Amazones patient association! The SIRIC ILIAD, Site de
SIRIC ILIAD shares the progress of its research with its partners
The SIRIC ILIAD Partners and Patient Representatives Committee met on 11 September to present its mid-term review. On 11 September
